UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
or

Pds Biotechnology Corp (PDSB)

Pds Biotechnology Corp (PDSB)
1.0399 -0.0001 (-0.01%) 10:39 ET [NASDAQ]
1.0300 x 4 1.0400 x 2
Realtime by (Cboe BZX)
1.0300 x 4 1.0400 x 2
Realtime - - (-) -
Quote Overview for Wed, Apr 16th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
1.0399
Day High
1.1000
Open 1.0500
Previous Close 1.0400 1.0400
Volume 15,635 15,635
Avg Vol 275,801 275,801
Stochastic %K 50.32% 50.32%
Weighted Alpha -57.71 -57.71
5-Day Change +0.0967 (+10.04%) +0.0967 (+10.04%)
52-Week Range 0.8500 - 4.4200 0.8500 - 4.4200
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 47,212
  • Shares Outstanding, K 45,396
  • Annual Sales, $ 0 K
  • Annual Income, $ -37,610 K
  • EBIT $ -36 M
  • EBITDA $ -35 M
  • 60-Month Beta 1.50
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.18

Options Overview Details

View History
  • Implied Volatility 221.37% ( -514.62%)
  • Historical Volatility 81.42%
  • IV Percentile 63%
  • IV Rank 28.68%
  • IV High 735.99% on 04/14/25
  • IV Low 14.38% on 06/10/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 50
  • Volume Avg (30-Day) 137
  • Put/Call OI Ratio 0.01
  • Today's Open Interest 7,521
  • Open Int (30-Day) 7,208

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.27
  • Number of Estimates 2
  • High Estimate -0.19
  • Low Estimate -0.34
  • Prior Year -0.30
  • Growth Rate Est. (year over year) +10.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.8500 +24.71%
on 04/07/25
Period Open: 1.3400
1.4300 -25.87%
on 03/18/25
-0.2800 (-20.90%)
since 03/17/25
3-Month
0.8500 +24.71%
on 04/07/25
Period Open: 1.4500
2.2000 -51.82%
on 02/27/25
-0.3900 (-26.90%)
since 01/17/25
52-Week
0.8500 +24.71%
on 04/07/25
Period Open: 2.7200
4.4200 -76.02%
on 07/16/24
-1.6600 (-61.03%)
since 04/17/24

Most Recent Stories

More News
PDS Biotech Announces Preclinical Influenza Data to be Presented in Symposium at IMMUNOLOGY2025™ Annual Meeting

PDSB : 1.0399 (-0.01%)
PDS Biotech Announces PDS01ADC Clinical Data to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2025

PDSB : 1.0399 (-0.01%)
PDS Biotechnology Stock In Spotlight On Better-Than-Feared 2024 Loss – Retail Stays Bearish

The company said the reduced losses were primarily due to decreased operating expenses.

VXF : 160.78 (+0.07%)
PDSB : 1.0399 (-0.01%)
VTI : 258.22 (unch)
PDS Biotech Reports Full Year 2024 Financial Results and Provides Clinical Programs Update

PDSB : 1.0399 (-0.01%)
PDS Biotech Leadership to Present at 2025 CAGLA NeauxCancer Conference

PDSB : 1.0399 (-0.01%)
PDS Biotech Announces Conference Call and Webcast for Full Year 2024 Financial Results

PDSB : 1.0399 (-0.01%)
PDS Biotech Announces FDA Clearance of IND Application for Combination of Versamune® MUC1 and PDS01ADC to Treat Metastatic Colorectal Cancer

PDSB : 1.0399 (-0.01%)
PDS Biotech Leadership to Participate in March Conferences

PDSB : 1.0399 (-0.01%)
PDS Biotech Initiates VERSATILE-003 Phase 3 Clinical Trial Evaluating Versamune® HPV in HPV16-Positive Head and Neck Cancer

PDSB : 1.0399 (-0.01%)
PDS Biotech Announces up to $22 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

PDSB : 1.0399 (-0.01%)

Business Summary

PDS Biotechnology Corp. is an immuno-oncology company. It is focused on developing a pipeline of clinical-stage immunotherapies to treat cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, cancer and other cancers. The company's products are based on the proprietary...

See More

Key Turning Points

3rd Resistance Point 1.2100
2nd Resistance Point 1.1600
1st Resistance Point 1.1000
Last Price 1.0399
1st Support Level 0.9900
2nd Support Level 0.9400
3rd Support Level 0.8800

See More

52-Week High 4.4200
Fibonacci 61.8% 3.0563
Fibonacci 50% 2.6350
Fibonacci 38.2% 2.2137
Last Price 1.0399
52-Week Low 0.8500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro

Info When You Need It Most.

Barchart Premier is one of the most powerful tools in the investment world. Come see why so many subscribers love it — and try it risk-free for 30 days.